Bliss GVS Pharma Limited Share Price and Company Fundamentals
Last traded: Last Friday at 9:59 AM
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotion, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, shampoo, soaps, sprays, and vaginal washes. In addition, it offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Key Metrics
PE ratio
19.93
PB ratio
1.89
Dividend yield
0.49%
Beta
0.94
Market cap
₹21.50B
Enterprise value
₹20.38B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 966 |
| Website | https://www.blissgvs.com |
| Mailing address | 102, Hyde Park Saki Vihar Road Andheri (East) Mumbai 400072 India |
| Phone / Fax | 91 22 4216 0000 / 91 22 2856 3930 |
Dividends
Dividend yield
0.49%
Dividend amount
₹1.00
Payout ratio
4.91%
5Y Avg. yield
-%
Bliss GVS Pharma Limited paid ₹1.00 dividend and the ex-dividend date was 18 Feb 2026.The dividend payout ratio is 4.91%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BLISSGVS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Bliss GVS Pharma Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Shibroor Narsimha Kamath | Chief Executive Officer | 72 | |
| Mr. Deepak B. Sawant | Chief Financial Officer | 45 | |
| Mr. Prashant Churi | Vice President of Technical Operations | ||
| Ms. Aditi Himanshu Bhatt | Compliance Officer, Company Secretary & Nodal Officer | ||
| Mr. Shreekrushna Joshi | Head of Legal | ||
| Mr. Sourya Das | Associate Vice President |
Profitability and management effectiveness
Profit margin
12.57%
Operating margin
12.11%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Bliss GVS Pharma Limited is 21.50B and its enterprise value is 20.38B. The enterprise value to revenue ratio of BLISSGVS is 2.35. The enterprise value to EBITDA ratio of BLISSGVS is 15.23.
The BLISSGVS's stocks Beta value is 0.94 making it 6% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Bliss GVS Pharma Limited (NSE:BLISSGVS) Frequently Asked Questions
1. What is Bliss GVS Pharma Limited's Stock Symbol?
Bliss GVS Pharma Limited trades on NSE under the ticker symbol "BLISSGVS".
2. What is Bliss GVS Pharma Limited's stock price today?
One share of BLISSGVS stock can currently be purchased for approximately ₹203.11.
3. How can I contact Bliss GVS Pharma Limited?
Bliss GVS Pharma Limited's mailing address is 102, Hyde Park Saki Vihar Road Andheri (East) Mumbai 400072 India. The company can be reached via phone at 91 22 4216 0000.
4. What is Bliss GVS Pharma Limited's official website?
The official website of Bliss GVS Pharma Limited is https://www.blissgvs.com.